La cadena de opciones muestra datos clave de las opciones de acciones de Burning Rock Biotech a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Burning Rock Biotech..

Burning Rock Biotech (NASDAQ:BNR) Bolsa, Cadena de Opciones

Burning Rock Biotech

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech Ltd

Brenmiller Energy Ltd

WIIM

CBUS

Cibus shares are trading lower after the company announced a proposed public offering.

BARK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BARK#NYSE">BARK</a>) sees Q1 sales of $99.000 million-$101.000 million vs $127.83 million analyst estimate.

News

Guidance

BARK

BARK Sees Q1 Sales $99.000M-$101.000M vs $127.83M Est

On June 4, 2025, Nelnet, Inc. ("Nelnet") received cash proceeds of $411 million as a result of redeeming certain of its membership interests of ALLO Holdings LLC ("ALLO") under a Membership Unit Redemption Agreement previously reported on a Current Report on Form 8-K filed on April 21, 2025.
 &nbsp;
As part of this transaction, Nelnet redeemed a portion of its voting membership interests of ALLO and all its outstanding preferred membership interests, including the preferred return accrued on such membership interests through June 3, 2025. As a result of the redemption, Nelnet recognized a pre-tax gain of $175 million.
 &nbsp;
Immediately following the closing of the transaction, Nelnet no longer owns any preferred membership interests of ALLO, but maintains a significant voting equity investment in ALLO. Nelnet's ownership of ALLO decreased from 45% to 27%. Nelnet will continue to account for its remaining 27% voting membership interests of ALLO under the Hypothetical Liquidation at Book Value (HLBV) method of accounting, with a carrying value of $0.

Contracts

Nelnet Redeems ALLO Holdings Membership Interests For $411M, Realizes $175M Pre-Tax Gain, Reduces Ownership From 45% To 27%

Cibus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBUS#NASDAQ">CBUS</a>) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it intends to offer shares of its Class A common stock (or common stock equivalents in lieu thereof) in a public offering. All of the securities to be sold in the offering are to be offered by Cibus. The Chairman of Cibus' board of directors, Mr. Rory Riggs, has indicated an interest in purchasing up to $10.0 million of shares of Class A common stock and/or common stock equivalents in this offering. Because such an indication of interest is not a binding agreement or commitment to purchase, Mr. Riggs may elect not to purchase any shares in this offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.
The Company currently intends to use the net proceeds from the offering to fund further development of the Company's weed management productivity traits in Rice and for working capital and general corporate purposes, as it pursues longer-term financing.

Offerings

Insider Trades

Cibus Announces Public Offering Of Class A Common Stock; Chairman Rory Riggs Signals Interest In Up To $10M Purchase Of Shares Of Class A Common Stock And/Or Common Stock Equivalents In This Offering

Five Below Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) reported first-quarter financial results Wednesday after the market close. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/06/g45780121/five-below-inc-announces-first-quarter-fiscal-2025-financial-results">from the quarter</a>.
<ul class="wp-block-list">
<li>Q1 Revenue:&nbsp;$970.5 million, versus&nbsp;<a href="https://www.benzinga.com/quote/FIVE/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $966.49 million</li>
<li>Q1 Adjusted EPS:&nbsp;86 cents, versus estimates of 82 cents</li>
</ul>
Total revenue was up 19.5% year-over-year, while comparable sales increased 7.1% year-over-year. The company reported operating income of $50.8 million in the first quarter.&nbsp;
Five Below opened 55 new stores in the quarter, bringing total locations up to 1,826 at quarter's end. The company ended the period with $427.46 million in cash and cash equivalents.
&#8220;Our&nbsp;first quarter&nbsp;results demonstrate the effectiveness of our strategy, grounded in trend-right product, extreme value and a fun store experience. We were pleased to see broad-based strength across the majority of our merchandising worlds, resulting in a transaction-driven&nbsp;7.1%&nbsp;increase in comparable sales, as well as strong performance from our new stores,&#8221; said&nbsp;Winnie Park, CEO of Five Below.
The company noted that CFO Kristy Chipman has decided to step down from her roles for personal reasons. COO Ken Bull will take on the role of interim CFO as the company searches for a replacement.
Outlook:&nbsp;Five Below expects second-quarter revenue in the range of $975 million to $995 million versus estimates of $958.31 million. The company anticipates second-quarter adjusted earnings of 50 cents to 62 cents per share versus estimates of 56 cents per share.&nbsp;
Five Below also raised guidance for full-year 2025. The company sees full-year revenue of $4.33 billion to $4.42 billion, up from prior guidance of $4.21 billion to $4.33 billion. The company expects full-year adjusted earnings to be between $4.25 and $4.72 per share, up from prior guidance of $4.10 to $4.72 per share. Analysts currently anticipate full-year revenue of $4.37 billion and earnings of $4.76 per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
&#8220;Looking ahead, this unwavering focus on the core customer combined with disciplined execution of our strategy and the agility of our teams position us to deliver our financial and operational objectives as we navigate the impact of tariffs and the associated uncertainty in the current global trade environment,&#8221; Park said.
Five Below executives will further discuss the quarter on a call with investors and analysts at 4:30 p.m. ET.
FIVE Price Action: <a href="http://benzinga.com/quote/five" target="_blank" rel="noreferrer noopener">Five Below shares</a> were up 0.63% in after-hours, trading at $123.83 at the time of publication on Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/06/45748544/walmart-leverages-automation-and-ai-to-cut-costs-and-grow-paving-the-way-for-other-retailers-report">Walmart Leverages Automation And AI To Cut Costs And Grow, Paving The Way For Other Retailers: Report</a></li>
</ul>
Photo: Retail Photographer/Shutterstock.

Earnings

After-Hours Center

Movers

FIVE

Five Below Q1 Earnings: Revenue, EPS Beat, Retailer Raises Guidance, CFO Will Step Down

XELB

Xcel Brands shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) is looking for Q2 Adj EPS of $1.85-2.00 vs $2.46 analyst estimate..

PVH Sees Q2 Adj EPS $1.85-2.00 vs $2.46 Est

CHPT

ChargePoint Holdings shares are trading lower after the company reported worse-than-expected Q1 sales results and issued Q2 sales guidance below estimates.

With the broader technology sector enjoying a resurgence, several of the usual suspects have benefited tremendously from the momentum spike. Still, Teradyne Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>), a leading supplier of automated test equipment (ATE) and industrial automation solutions, has lagged its innovation-centric peers. At the same time, the potential trickle-down effect could lift TER stock, making it both a possible value investment and an intriguing trade.
Recently, the tech-oriented Nasdaq Composite eked into positive territory for the year, symbolizing the resurgence that has taken place among publicly traded innovators. Over the past 52 weeks, the index has now gained over 15%. Terdayne, though, has not shared in the enthusiasm. On a year-to-date basis, TER stock is down more than 34%. Over the past 52 weeks, it has lost nearly 41%.
Nevertheless, there's legitimate cause for optimism. Semiconductor juggernauts like Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) have regained their mojo in recent sessions. Part of the enthusiasm could be traced to catalysts such as the "TACO" trade, a crude acronym that stands for ‘Trump Always Chickens Out.'
Essentially, the market is digesting President Donald Trump's tariff policies and accompanying aggressive rhetoric. Initially, the tariffs sparked great concern among investors, leading to severe volatility. However, Trump has a tendency of <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45715677/tom-lee-bets-on-a-new-bull-market-as-trumps-tariff-retreat-fuels-taco-trade-amid-run-it-hot-optimism">talking tough first and then walking back the bravado</a>. The market has noticed and is responding accordingly.
Subsequently, concerns about the impact of retaliatory measures against the tech sector has lessened somewhat. Combined with <a href="https://www.benzinga.com/news/25/05/45671751/amd-stock-rises-on-nvidias-blowout-quarter-and-ai-momentum">strong earnings results</a> from the semiconductor space, the landscape appears compelling for TER stock. Fundamentally, that's because advanced chips are incredibly complex, requiring rigorous testing protocols. Since this process represents Teradyne's bread and butter, TER presents an intriguing value proposition.
It also might make for a quick trade.
<h2 class="wp-block-heading">A Sentiment Reversal Could Be Due For TER Stock</h2>
To be completely fair, the <a href="https://www.benzinga.com/news/24/08/40422222/teradyne-positioned-for-ai-growth-with-strong-robotics-and-auto-test-markets-analyst-upgrades-stock">fundamental argument</a> that Teradyne's behind-the-scenes relevance should boost its business was mentioned last year. As stated earlier, TER stock has lost a massive amount of equity value since that argument was issued. This goes to show how investing narratives — no matter how convincing — aren't necessarily the best predictors.
On the flipside, when it comes to the discipline of trading, predictability runs at the heart of the speculative practice. Traders aren't necessarily focused on the narratives, though they provide important context. Storylines represent the "why" of a target enterprise or asset. Traders are focused on the "how" — how much, how fast, how likely.
In other words, the central theme in options is probability: how likely is it that a particular stock will meet its profitability threshold within an allocated time period? To answer this question, traders should turn to market breadth or the assessment of patterns of accumulation and distribution.
Ordinarily, financial experts will turn to fundamental and technical analysis to aid in their decision-making process. Unfortunately, these methodologies are only partially useful because of their property of non-stationarity. That's the academic way of saying that core metrics such as earnings growth or share price generally fluctuate, especially across vast time periods and sentiment regimes.
For example, TER stock was trading around $20 a share a decade ago. It's above $82 today, meaning that statistical clustering is really only applicable for a narrow time range. In contrast, market breadth is simply demand and demand is a binary construct. Such constructs existed in 2015 and they're applicable today.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04152119/TER-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-938723" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04152119/TER-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04152119/TER-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04152119/TER-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04152119/TER-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
In the past two months, TER stock printed a "3-7-D" market breadth sequence: three up weeks, seven down weeks, with a net negative trajectory across the 10-week period. Notably, in 60.71% of cases, the following week's price action results in upside, with a median return of 5.25%. Based on Friday's close of $78.60, TER is on track to hit $82.73, which is now a very realistic target.
Should the bulls maintain control of the market, the median return for the second week stands at 2.75%. If so, that should push TER stock a hair over the $85 level.
<h2 class="wp-block-heading">Getting Down To Business</h2>
Using the above market intelligence, the most rational multi-leg options strategy may be the 80/85 bull call spread expiring June 20. This transaction involves buying the $80 call and simultaneously selling the $85 call, for a net debit paid of $270. Should TER stock rise through the short strike price at expiration, the maximum reward is $230, a payout of over 85%.
Primarily, what makes this trade attractive is the implied shift in sentiment. In any given week, the chance that a long position in TER stock will be profitable is 54.04%. As it stands, bullish traders have a modest edge. Coming off the back of the 3-7-D sequence, these traders enjoy an extra boost in probability, thus incentivizing a debit-based strategy.
Read Next:
<a href="https://www.benzinga.com/markets/options/25/06/45757550/tsla-stock-elon-musk-return-probabilistic-bullish-edge">Options Corner: Tesla Offers A 65% Probabilistic Edge That Favors The Bullish Trader</a>
Photo: Shutterstock

Equities

Long Ideas

Options

NVDA

Options Corner: Teradyne's Value Proposition Also Bodes Well For Swing Traders

Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) ("Transocean") today announced that a two-well option was exercised for the Transocean Spitsbergen in Norway. The program is expected to commence in the first quarter of 2026 in direct continuation of the rig's current program and contribute approximately $100 million in backlog, excluding additional services.

Transocean Secures $100M Contract Extension For Spitsbergen Rig In Norway, With Two-Well Program Set To Begin In Early 2026

Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(1.12) by 48.21 percent. This is a 34.09 percent increase over losses of $(0.88) per share from the same period last year. The company reported quarterly sales of $1.33 million which met the analyst consensus estimate. This is a 39.01 percent decrease over sales of $2.18 million the same period last year.

Earnings Beats

Xcel Brands Q1 Adj. EPS $(0.58) Beats $(1.12) Estimate, Sales $1.33M Inline

PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) lowers FY2025 Adj EPS guidance from $12.40-12.75 to $10.75-11.00 vs $12.52 analyst estimate..

PVH Lowers FY2025 Adj EPS Guidance from $12.40-12.75 to $10.75-11.00 vs $12.52 Est

VBIX

Viewbix Approved For Nasdaq Capital Market Listing, Set To Begin Trading On June 5, 2025

PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) reported quarterly earnings of $2.30 per share which beat the analyst consensus estimate of $2.25 by 2.22 percent. This is a 6.12 percent decrease over earnings of $2.45 per share from the same period last year. The company reported quarterly sales of $1.98 billion which beat the analyst consensus estimate of $1.93 billion by 2.55 percent. This is a 1.64 percent increase over sales of $1.95 billion the same period last year.

PVH Q1 Adj. EPS $2.30 Beats $2.25 Estimate, Sales $1.98B Beat $1.93B Estimate

Costco Wholesale Corporation ("Costco" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) today reported net sales of $20.97 billion for the retail month of May, the four weeks ended June 1, 2025, an increase of 6.8 percent from $19.64 billion last year.
Net sales for the first 39 weeks were $201.02 billion, an increase of 8.0 percent from $186.07 billion last year.
Comparable sales for the periods ended June 1, 2025, were as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1">4 Weeks</td>
<td colspan="1">39 Weeks</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>U.S.</td>
<td>4.1%</td>
<td>6.5%</td>
</tr>
<tr>
<td>Canada</td>
<td>3.3%</td>
<td>4.4%</td>
</tr>
<tr>
<td>Other International</td>
<td>6.6%</td>
<td>3.4%</td>
</tr>
<tr>
<td>Total Company</td>
<td>4.3%</td>
<td>5.8%</td>
</tr>
<tr>
<td>E-commerce</td>
<td>11.6%</td>
<td>15.8%</td>
</tr>
</tbody>
</table>
</figure>
Comparable sales excluding the impacts from changes in gasoline prices and foreign exchange were as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1">4 Weeks</td>
<td colspan="1">39 Weeks</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>U.S.</td>
<td>5.5%</td>
<td>7.7%</td>
</tr>
<tr>
<td>Canada</td>
<td>6.3%</td>
<td>8.2%</td>
</tr>
<tr>
<td>Other International</td>
<td>8.4%</td>
<td>8.6%</td>
</tr>
<tr>
<td>Total Company</td>
<td>6.0%</td>
<td>7.9%</td>
</tr>
<tr>
<td>E-commerce</td>
<td>12.0%</td>
<td>16.6%</td>
</tr>
</tbody>
</table>
</figure>
Additional discussion of these results is available in a pre-recorded message. It can be accessed by visiting investor.costco.com (click on "Events &amp; Presentations"). This message will be available through 4:00 p.m. (PT) on Wednesday, June 11, 2025.

COST

Costco Wholesale Reports Net Sales Of $20.97B For The Retail Month Of May, The Four Weeks Ended June 1, 2025, An Increase Of 6.8% From $19.64B Last Year

ChargePoint Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) sees Q2 sales of $90.000 million-$100.000 million vs $108.07 million analyst estimate.

ChargePoint Hldgs Sees Q2 Sales $90.000M-$100.000M vs $108.07M Est

MongoDB shares are trading higher after the company reported better-than-expected Q1 financial results, issued Q2 adjusted EPS guidance above estimates and raised its FY26 guidance. Also, the company announced an additional share repurchase authorization of $800 million.

Fastenal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) has outperformed the market over the past 20 years by 4.35% on an annualized basis producing an average annual return of 12.67%. Currently, Fastenal has a market capitalization of $46.90 billion. 
Buying $1000 In FAST: If an investor had bought $1000 of FAST stock 20 years ago, it would be worth $11,067.34 today based on a price of $40.88 for FAST at the time of writing.
<h3>Fastenal's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749068124_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

FAST

Here's How Much $1000 Invested In Fastenal 20 Years Ago Would Be Worth Today

<a href="https://www.globenewswire.com/Tracker?data=S4UnlmlTicwfl7_RRYUIaJCEasXISs9EycTSOcVh_8azaFsCh0CinUK1yo5SofulLAKIKAtP-f-DUJ31ao-oLvkdfEv6CH70DJ0y4rTenXM=">Cipher Mining Inc.</a> (NASDAQ:<a href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) ("Cipher" or the "Company") today released its unaudited production and operations update for May 2025.
Key Highlights
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Key Metrics</td>
<td>May 2025</td>
</tr>
<tr>
<td>BTC Mined1</td>
<td>179</td>
</tr>
<tr>
<td>BTC Sold</td>
<td>64</td>
</tr>
<tr>
<td>BTC Held2</td>
<td>966</td>
</tr>
<tr>
<td>Deployed Mining Rigs</td>
<td>75,000</td>
</tr>
<tr>
<td>Month End Operating Hashrate (EH/s)</td>
<td>13.5</td>
</tr>
<tr>
<td>Month End Fleet Efficiency (J/TH)</td>
<td>18.9</td>
</tr>
</tbody>
</table>
</figure>
1 Includes May power sales estimates (based on current meter data and nodal prices) equivalent to ~4 bitcoin (using month-end bitcoin price of $104,430) and ~23 BTC mined at JV data centers representing Cipher's ownership
2 Includes ~334 BTC pledged as collateral&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;

CIFR

Cipher Mining Announces May 2025 Operational Update; 179 BTC Mined; 966 BTC Held

ChargePoint Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $97.64 million which missed the analyst consensus estimate of $100.53 million by 2.87 percent. This is a 8.78 percent decrease over sales of $107.04 million the same period last year.

Comments

Burning Rock Biotech

Burning Rock Biotech (BNR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL